Back
28
Day Range
$183.28
$187.59
52-Week Range
$168.14
$310.50
Volume
1,566,951
50D / 200D Avg
$196.45
/
$254.18
Prev Close
$184.07
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 33.5 | 0.4 |
| P/B | 4.2 | 2.9 |
| ROE % | 13.9 | 3.8 |
| Net Margin % | 28.4 | 3.9 |
| Rev Growth 5Y % | 14.6 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 14.63% annually over 5 years — strong growth
Earnings grew 27.27% over the past year
ROE of 13.93% — decent returns on equity
Net margin of 28.44% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 1.39B in free cash flow
Growth
Revenue Growth (5Y)
14.63%
Revenue (1Y)16.34%
Earnings (1Y)27.27%
FCF Growth (3Y)25.14%
Quality
Return on Equity
13.93%
ROIC9.40%
Net Margin28.44%
Op. Margin28.68%
Safety
Debt / Equity
0.01
Current Ratio4.89
Interest Coverage0.00
Valuation
P/E Ratio
33.50
P/B Ratio4.22
EV/EBITDA31.78
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.34% | Revenue Growth (3Y) | 16.27% |
| Earnings Growth (1Y) | 27.27% | Earnings Growth (3Y) | 31.49% |
| Revenue Growth (5Y) | 14.63% | Earnings Growth (5Y) | 20.76% |
| Profitability | |||
| Revenue (TTM) | 3.20B | Net Income (TTM) | 908.91M |
| ROE | 13.93% | ROA | 10.12% |
| Gross Margin | 75.53% | Operating Margin | 28.68% |
| Net Margin | 28.44% | Free Cash Flow (TTM) | 1.39B |
| ROIC | 9.40% | FCF Growth (3Y) | 25.14% |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 4.89 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 33.50 | P/B Ratio | 4.22 |
| P/S Ratio | 9.53 | PEG Ratio | 1.42 |
| EV/EBITDA | 31.78 | Dividend Yield | 0.00% |
| Market Cap | 30.45B | Enterprise Value | 29.12B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.20B | 2.75B | 2.36B | 2.16B | 1.85B |
| Net Income | 908.91M | 714.14M | 525.71M | 487.71M | 427.39M |
| EPS (Diluted) | 5.44 | 4.32 | 3.22 | 3.00 | 2.63 |
| Gross Profit | 2.41B | 2.05B | 1.69B | 1.55B | 1.35B |
| Operating Income | 916.37M | 691.44M | 429.33M | 459.09M | 505.50M |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 8.98B | 7.34B | 5.91B | 4.80B | 3.82B |
| Total Liabilities | 1.76B | 1.51B | 1.27B | 1.09B | 904.83M |
| Shareholders' Equity | 7.21B | 5.83B | 4.64B | 3.72B | 2.91B |
| Total Debt | 95.86M | 75.78M | 55.78M | 60.98M | 54.59M |
| Cash & Equivalents | 1.42B | 1.12B | 703.49M | 886.47M | 1.14B |
| Current Assets | 8.00B | 6.31B | 5.00B | 3.97B | 3.11B |
| Current Liabilities | 1.64B | 1.40B | 1.18B | 1.01B | 840.78M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#849 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026